SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026075
Filing Date
2017-05-10
Accepted
2017-05-10 16:32:36
Documents
41
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v465542_10q.htm 10-Q 502687
2 EXHIBIT 10.1 v465542_ex10-1.htm EX-10.1 16242
3 EXHIBIT 10.2 v465542_ex10-2.htm EX-10.2 12759
4 EXHIBIT 31.1 v465542_ex31-1.htm EX-31.1 10362
5 EXHIBIT 31.2 v465542_ex31-2.htm EX-31.2 10126
6 EXHIBIT 32.1 v465542_ex32-1.htm EX-32.1 3735
7 EXHIBIT 32.2 v465542_ex32-2.htm EX-32.2 3736
  Complete submission text file 0001144204-17-026075.txt   2394939

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ck0001651407-20170331.xml EX-101.INS 339770
9 XBRL TAXONOMY EXTENSION SCHEMA ck0001651407-20170331.xsd EX-101.SCH 25366
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001651407-20170331_cal.xml EX-101.CAL 17092
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001651407-20170331_def.xml EX-101.DEF 175712
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001651407-20170331_lab.xml EX-101.LAB 185110
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001651407-20170331_pre.xml EX-101.PRE 197889
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55506 | Film No.: 17830815
SIC: 2834 Pharmaceutical Preparations